There was no significant difference in FAM19A4 methylation associated with ages, pathological types, clinical stage (FIGO, 2009), tumor size, lymph node metastasis, or HPV infection types (P > 0.05) (Table 3). This evidence concerns the gene TAFA4 and neoplasm.